Search results
Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030,...
Business Insider via Yahoo Finance· 1 day agoZepbound is Eli Lilly's new weight-loss drug.Brendan McDermid/Reuters The anti-obesity drug market...
Eli Lilly adds ALS drug prospect with QurAlis deal
BioPharma Dive via Yahoo Finance· 15 hours agoThe alliance hands Lilly an RNA-based therapy in preclinical testing for ALS and frontotemporal dementia, and includes a research collaboration to...
Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?
Investor's Business Daily· 4 days agoEli Lilly stock rocketed and broke out earlier this month after unveiling promising results for its...
Watch Out Wegovy: Here Comes Another Promising Anti-Obesity Candidate | The Motley Fool
The Motley Fool· 6 hours agoInvestors interested in the pharmaceutical industry are currently excited about the anti-obesity...
Lilly gilds neuro pipeline, paying QurAlis $45M for preclinical ALS, dementia prospect
FierceBiotech· 11 hours agoEli Lilly is splicing another asset onto its neurodegenerative disease pipeline, paying QurAlis $45 million for rights to a preclinical treatment for amyotrophic ...
This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors | The Motley Fool
The Motley Fool· 2 days agoEli Lilly (LLY 0.65%) and Novo Nordisk (NVO 1.87%) are the two most valuable healthcare companies in...
Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030,...
Business Insider· 2 days agoThe anti-obesity drug market will be worth $130 billion by 2030, Goldman Sachs analysts said in a...
These Are The 5 Best Stocks To Buy And Watch Now
Investor's Business Daily· 18 hours agoBuying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a...
Is Eli Lilly And Co (NYSE:LLY) the Best Weight Loss Stock to Buy in 2024?
Insider Monkey via Yahoo Finance· 3 days agoWe recently published a list of Jim Cramer’s Top 10 Stock Picks for June. Since Eli Lilly And Co...
This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors
Motley Fool via Yahoo Finance· 2 days agoEli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are the two most valuable healthcare companies in...